| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.008 |